Vagus Nerve Stimulation for Parkinson's Disease

This trial explores how gentle electrical stimulation of the vagus nerve, applied to the ear, might improve thinking skills like decision-making in both healthy individuals and those with Parkinson's disease (PD). The process, known as transcutaneous auricular vagus nerve stimulation (taVNS), could potentially boost brain function. Participants may receive either active or sham (non-active) stimulation to assess its effects. This trial suits those with Parkinson's who don't have severe movement or thinking issues, as well as healthy individuals willing to participate. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research that could enhance cognitive health.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.

Research has shown that gentle electrical stimulation on the ear, known as transcutaneous auricular vagus nerve stimulation (taVNS), is generally safe. Studies have found that while minor side effects can occur, no serious problems have been linked to this treatment. Participants in these studies, including those with Parkinson's disease, have found taVNS easy to tolerate. This suggests that taVNS is a safe option for those considering joining a clinical trial.¹²³⁴⁵

Most treatments for Parkinson's Disease, like levodopa and dopamine agonists, work by increasing dopamine levels in the brain. However, transcutaneous auricular vagus nerve stimulation (taVNS) offers a different approach by non-invasively stimulating the vagus nerve to potentially improve neurological function. Researchers are excited about taVNS because it provides a novel way to target brain circuits involved in Parkinson's without the need for medication, which can have significant side effects. This method could offer a new avenue for managing symptoms, especially for those who may not respond well to traditional therapies.

This trial will evaluate transcutaneous auricular vagus nerve stimulation (taVNS) for Parkinson's disease. Studies have shown that taVNS can improve movement problems common in Parkinson's. Research also suggests it can aid with issues like sleep and overall quality of life. Some studies report small improvements in walking speed and stride length. Overall, taVNS appears to be a promising option for enhancing certain aspects of life for those with Parkinson's disease.¹²³⁴⁶